Multicenter Reproducibility of ¹⁸F-Fluciclatide PET Imaging in Subjects with Solid Tumors

Abstract

The test-retest reproducibility of (18)F-fluciclatide across multiple tumor types has been measured and shown to be acceptable. This is an important step in the development of this in vivo biomarker to identify and quantify response to antiangiogenic therapy in cancer patients.